Featured Research

from universities, journals, and other organizations

Exercise may reduce risk of endometrial cancer

Date:
November 12, 2010
Source:
American Association for Cancer Research
Summary:
Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to new research.

Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10 in Philadelphia.

"This study is consistent with other studies that strongly support the association between physical activity and lower risk of endometrial cancer," said Hannah Arem, a doctoral student at Yale School of Public Health.

Arem and colleagues examined data collected from a case-control study led by Herbert Yu, M.D., M.Sc., Ph.D., associate professor at Yale School of Public Health. The study included 668 women with endometrial cancer and compared them to 665 age-matched control women.

Those who exercised for 150 minutes a week or more had a 34 percent reduced risk of endometrial cancer compared with those women who were inactive.

This association was more pronounced among active women with a body mass index (BMI) less than 25, or underweight women, where the reduction in risk was 73 percent compared with inactive women with a BMI more than 25, or what is commonly considered overweight.

Although BMI showed a strong association with endometrial cancer, even women who were overweight, but still active, had a 52 percent lower risk.

"Clearly, programs should be in place to increase the level of physical activity in women," said Arem.


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "Exercise may reduce risk of endometrial cancer." ScienceDaily. ScienceDaily, 12 November 2010. <www.sciencedaily.com/releases/2010/11/101109133139.htm>.
American Association for Cancer Research. (2010, November 12). Exercise may reduce risk of endometrial cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/11/101109133139.htm
American Association for Cancer Research. "Exercise may reduce risk of endometrial cancer." ScienceDaily. www.sciencedaily.com/releases/2010/11/101109133139.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins